Stem Cell Transplant Approaches to MDS

An individualized sequential alloSCT approach in patients with R/R AML or HR-MDS with active diseaseПодробнее

An individualized sequential alloSCT approach in patients with R/R AML or HR-MDS with active disease

A total approach to MDS and unanswered questions in the fieldПодробнее

A total approach to MDS and unanswered questions in the field

MDS 2023: PS 10 - Innovations in Transplantation and Cellular Immunotherapy for MDS PatientsПодробнее

MDS 2023: PS 10 - Innovations in Transplantation and Cellular Immunotherapy for MDS Patients

MDS 2023: PS 7 - Non Targeted Approaches for HR MDSПодробнее

MDS 2023: PS 7 - Non Targeted Approaches for HR MDS

Approaching patients with MDS and AML who relapse after alloSCT & strategies to prevent relapseПодробнее

Approaching patients with MDS and AML who relapse after alloSCT & strategies to prevent relapse

Hematopoietic Stem Cell TransplantationПодробнее

Hematopoietic Stem Cell Transplantation

Methods of optimizing transplantation in MDSПодробнее

Methods of optimizing transplantation in MDS

Immune therapy approaches in MDSПодробнее

Immune therapy approaches in MDS

Advancing the management of MDS and AML: Novel immune-based approachesПодробнее

Advancing the management of MDS and AML: Novel immune-based approaches

Stem Cell Transplantation: A session with MDS UK Patients and specialists from King's hospital.Подробнее

Stem Cell Transplantation: A session with MDS UK Patients and specialists from King's hospital.

Comprehensive Management Approach for Patients with Bone Marrow Failure Conditions | UPMC Children'sПодробнее

Comprehensive Management Approach for Patients with Bone Marrow Failure Conditions | UPMC Children's

Pediatric BMT - Optimizing Outcomes After TransplantПодробнее

Pediatric BMT - Optimizing Outcomes After Transplant

How do MDS genetic mutations influence decisions for stem cell transplant?Подробнее

How do MDS genetic mutations influence decisions for stem cell transplant?

Stem cell transplant beneficial for older patients with myelodysplastic syndromeПодробнее

Stem cell transplant beneficial for older patients with myelodysplastic syndrome

What's New in MDS May 19 2021Подробнее

What's New in MDS May 19 2021

SESSION III HIGH RISK MDS - (English) - Latin-American GLAM and MDSF Symposium 2021Подробнее

SESSION III HIGH RISK MDS - (English) - Latin-American GLAM and MDSF Symposium 2021

MDS: Factors to Consider in the Initial Treatment ApproachПодробнее

MDS: Factors to Consider in the Initial Treatment Approach

From MDS to AML: What Every Patient Needs to Know 11/28/17Подробнее

From MDS to AML: What Every Patient Needs to Know 11/28/17

Webinar: Leveraging Multi-omic Approaches to Understand Disease Stem Cells in Myeloid MalignanciesПодробнее

Webinar: Leveraging Multi-omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Managing and Treating MDS-related AnemiaПодробнее

Managing and Treating MDS-related Anemia

События